TruBridge, Inc.

TruBridge, Inc. (TBRG) Market Cap

TruBridge, Inc. has a market capitalization of $393.6M.

Price: $26.24

0.00 (0.00%)

Market Cap: 393.58M

NASDAQ · time unavailable

CEO: Christopher L. Fowler

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2002-05-21

Website: https://www.trubridge.com

TruBridge, Inc. (TBRG) - Company Information

Market Cap: 393.58M|Sector: Healthcare

Company Profile

TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement. The company places a strong emphasis on its RCM offerings, which are designed to integrate seamlessly with any primary healthcare information solutions provider. These offerings are complemented by business management, consulting, managed IT services, and sophisticated analytics and business intelligence tools. Its extensive RCM services span the entire revenue cycle, including patient liability estimates, eligibility verification, precise claim scrubbing and submission, remittance and denial/audit management, and contract management. Further capabilities include accounts receivable management, private pay services, medical coding, specialized revenue cycle consulting, and a range of additional insurance and patient billing services. TruBridge also provides specialized acute care solutions and associated services for community hospitals and physician clinics. Moreover, it leverages patient engagement and empowerment technologies to enhance patient outcomes and improve interaction strategies with care providers. Beyond these, the company offers general consulting and business management expertise, managed IT services, encoder solutions, patient management, financial accounting, and a suite of clinical, patient care, and enterprise applications. Its flagship TruBridge HER platform is a robust offering, encompassing total system support, access to national client conferences, continuing education resources, regular software releases, hardware replacement, and cloud-based electronic health record functionality, all built upon a secure public cloud infrastructure. Additionally, TruBridge supplies post-acute care software systems with comprehensive support and maintenance, alongside innovative tools like InstantPHR (an interactive patient portal) and CHBase, which efficiently centralizes data from diverse sources. Founded in 1979, the company recently underwent a rebranding from Computer Programs and Systems, Inc. to TruBridge, Inc. in March 2024. Its corporate headquarters are located in Mobile, Alabama.

Analyst Sentiment

50%
Hold

From 4 Active Polls

1Y Forecast: $26.25

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$26

Median

$26

High Bound

$26

Average

$26

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$26.25
▲ +0.04% Upside
Low Target
$26.25
0% Risk
Median Target
$26.25
0% Mid
High Target
$26.25
0% Max
Consensus
Hold
7 / 22 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)394213320292340395282171151
Enterprise Value ($M)527346462459497556444343327
Price to Earnings Ratio (P/E)89.31108.28-19.7113.6334.44223.38-12.646.64-9.11
Price/Earnings-to-Growth Ratio (PEG)-10.0630.99-1.51-5.17
Price to Sales Ratio (P/S)1.142.473.643.393.974.533.102.041.77
Price to Book Ratio (P/B)2.141.191.801.621.962.351.670.990.84
Price to Free Cash Flow Ratio (P/FCF)9.3818.1838.1721.3841.41277.3245.9435.7216.53
Enterprise Value to Sales (EV/Sales)4.015.265.335.796.384.894.093.83
Enterprise Value to EBITDA (EV/EBITDA)16.1771.81162.5831.5647.9237.7931.5342.6643.96
Debt to Equity Ratio4.090.940.940.930.971.011.041.041.02

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 TRUBRIDGE INC (TBRG) — Investment Overview

🧩 Business Model Overview

TRUBRIDGE INC operates a technology-enabled services model built around embedding into customer workflows and back-office processes. The company’s value proposition centers on improving operational throughput for healthcare-oriented customers through software-assisted services and ongoing system support. Revenue is earned through platform access and related services, with the customer relationship strengthened over time by integrations, process familiarity, and accumulated operational history.

In practice, the business tends to follow a “land, integrate, then expand” pattern: initial contracts require configuration and onboarding into existing operational systems; ongoing work then becomes stickier as teams depend on the process design, exception handling routines, and the operational data history produced over time.

💰 Revenue Streams & Monetisation Model

TRUBRIDGE’s monetization is typically characterized by a blend of recurring software- or platform-linked fees and service-driven components that scale with customer activity. Margin structure generally depends on (1) utilization of service capacity, (2) the mix between recurring platform-like revenue versus transactional service revenue, and (3) the extent to which automation reduces incremental labor per unit of throughput.

Key margin drivers to underwrite include: gross margin sustainability as contract sizes scale; operating leverage from support and implementation functions amortized across the installed base; and the durability of customer subscriptions and renewals.

🧠 Competitive Advantages & Market Positioning

The company’s most defensible advantage is high switching costs. Once TRUBRIDGE solutions are integrated into daily workflows, customers face friction and risk in migrating processes, retraining staff, and re-establishing operational baselines. Over time, performance measurement, exception workflows, and historical operational data create “data gravity,” increasing the cost of displacement.

A secondary moat is the company’s operational know-how: process implementation and continuous improvement tend to compound as customer-specific playbooks are refined. While competitors may match features at the software layer, replicating outcomes typically requires comparable implementation depth and operational discipline.

  • Competitive benchmarking: primary competitors include athenahealth, NextGen Healthcare, and Epic (plus adjacent revenue-cycle and practice-management vendors). These rivals often compete on breadth of platform capabilities and enterprise reach.
  • Contrast in positioning: TRUBRIDGE’s approach typically emphasizes integrated workflow enablement and services-assisted execution, competing against larger platforms by focusing on adoption depth, operational workflow fit, and the stickiness created by ongoing process dependence rather than platform “breadth” alone.

🚀 Multi-Year Growth Drivers

  • Rising complexity in healthcare operations: documentation, billing requirements, and care-delivery workflows increase the value of process-guided platforms and operational support.
  • Installed-base expansion: installed customers often convert additional departments, additional sites, or additional workflow modules as confidence in outcomes grows.
  • Automation and workflow standardization: continued refinement of automation can lower incremental cost-to-serve while maintaining quality, supporting operating leverage over a 5–10 year horizon.
  • Data-driven operational performance: the same operational data that raises switching costs can enable continuous improvement and performance benchmarking, reinforcing retention.
  • Segment selection and specialization: focusing on customer sub-segments where integration depth matters can expand total addressable market beyond “general-purpose” incumbency.

⚠ Risk Factors to Monitor

  • Implementation and retention risk: if onboarding timelines, workflow fit, or service performance underdeliver, churn can rise—damaging the recurring revenue base that supports valuation.
  • Technological substitution: larger platforms and rapidly evolving point solutions may compress differentiation unless TRUBRIDGE sustains measurable workflow outcomes and continuous product iteration.
  • Concentration and contract structure: customer mix and the proportion of revenue tied to specific service volumes can create variability in performance and margins.
  • Operational scaling: scaling service capacity without degrading quality can be challenging; margin pressure may emerge if labor intensity does not fall as expected.
  • Security, privacy, and compliance: healthcare-adjacent operations require rigorous controls; any compliance lapse can create disproportionate reputational and financial harm.

📊 Valuation & Market View

The market typically values healthcare software-enabled service models through a mix of EV/Revenue and EV/EBITDA frameworks, with the key fundamental drivers being recurring revenue quality, retention, gross margin trajectory, and operating leverage. For this business type, valuation sensitivity usually increases when investors gain clarity on: (1) sustained renewal rates and customer expansion, (2) cost-to-serve efficiency from automation, and (3) the durability of unit economics.

Multiple compression risk is often linked to deterioration in retention, margin structure, or evidence of platform displacement. Multiple expansion is typically supported by visible operating leverage and stability in recurring components.

🔍 Investment Takeaway

TRUBRIDGE’s long-term thesis rests on customer stickiness created by switching costs—workflow integration, process dependence, and cumulative operational data—paired with an opportunity to drive operating leverage as automation improves the cost-to-serve. The investment case is strongest when underwriting focuses on retention durability, expansion within the installed base, and evidence that incremental service labor needs are structurally declining while quality metrics remain intact.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for TBRG.

newsfilecorp.com2026-07-30

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

globenewswire.com2026-07-28

TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public.

prnewswire.com2026-07-27

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

NEW YORK, July 27, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. So what: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com2026-07-24

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com2026-07-22

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

globenewswire.com2026-07-21

TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public.

prnewswire.com2026-07-20

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

NEW YORK, July 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. So what: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com2026-07-16

ROSEN, A TOP-RANKED LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

prnewswire.com2026-07-15

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

NEW YORK, July 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. So what: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com2026-07-12

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

globenewswire.com2026-07-11

TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public.

marketbeat.com2026-07-11

TruBridge Stockholders Approve IKS Merger at Special Meeting

TruBridge NASDAQ: TBRG stockholders approved the company's proposed merger agreement under which TruBridge will become a subsidiary of Inventurus Knowledge Solutions Inc., or IKS, during a virtual special meeting held July 7, 2026.

prnewswire.com2026-07-10

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

NEW YORK, July 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. So what: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com2026-07-08

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO WHAT: If you purchased TruBridge securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

globenewswire.com2026-07-07

TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"TBRG reported Q1’26 revenue of $86.3M and net income of $0.5M (EPS $0.03). On a YoY basis, revenue was down -1.1% versus Q1’25 ($87.2M) while net income improved meaningfully from $0.5M to $0.5M (effectively flat vs Q1’25). QoQ, revenue fell -1.7% versus Q4’25 ($87.8M), while profitability improved sharply from a net loss of -$4.3M in Q4’25 to +$0.5M in Q1’26; EPS moved from -$0.28 to +$0.03. Profitability in the latest quarter shows modest net margins (net margin ~0.6%) despite healthy gross margin (~55.5%). The key change QoQ is operating/income normalization: Q1’26 operating income is $3.1M (operating margin ~3.5%) versus Q4’25 operating income $5.0M but below net loss severity driven by large Q4 “other income/expense” effects (income before tax -$3.1M). Cash flow remains positive: operating cash flow was $15.5M and free cash flow was $14.4M in Q1’26, supporting balance-sheet flexibility. Balance sheet resilience is a relative positive for a non-bank: total assets were $407.5M and equity was $178.7M. Leverage is low by debt metrics (net debt ~-$29.0M; net cash position). Shareholder returns can’t be fully assessed without buyback/dividend data tied to market returns, but price momentum is muted: the stock is -3.65% over 1Y, so no >20% momentum tailwind."

Revenue Growth

Fair

Revenue was $86.3M in Q1’26, down -1.1% YoY (vs. $87.2M in Q1’25) and -1.7% QoQ (vs. $87.8M in Q4’25). Trend is slightly contracting.

Profitability

Neutral

Gross margin improved to ~55.5% in Q1’26 (from ~54.3% in Q4’25). Net margin rebounded to ~0.6% in Q1’26 from -4.9% in Q4’25; EPS turned to +$0.03 from -$0.28 QoQ.

Cash Flow Quality

Positive

Q1’26 operating cash flow was $15.5M and free cash flow was $14.4M, indicating strong cash generation despite low net margin. No dividends were paid; buybacks occurred ($1.29M repurchased), supporting shareholder value without stressing cash.

Leverage & Balance Sheet

Good

Balance sheet strengthened vs prior quarter: cash rose to $35.4M (from $24.9M in Q4’25) and equity rose slightly to $178.7M. Debt is modest with net cash position (net debt ~-$29.0M), implying resilience.

Shareholder Returns

Caution

Market performance is slightly negative over 1Y (-3.65%) with no strong momentum. Dividend yield is 0% per data; buybacks were small relative to market impact.

Analyst Sentiment & Valuation

Fair

Consensus target is ~$25.44 versus current price $23.25 (~+9.4% upside). No >20% upside/momentum signal from price targets; valuation multiples appear elevated (e.g., price/earnings based on small earnings).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Management delivered a generally upbeat margin story, with Q4 Adjusted EBITDA up to $19.2m and +160 bps margin expansion, and FY margins up +350 bps alongside $20m free cash flow. The company is also painting improving fundamentals via a pipeline that’s up +53% since Q3 and encoder pipeline growth of +74%, supported by Microsoft-related initiatives and Dragon Copilot integration. However, the Q&A undercuts the confidence: CBO retention remains a muted success story, with management describing 2026 as impacted by continued attrition from ’25 transitions and only “modest/improving flattish” improvement—without providing hard retention-rate numbers. Additionally, bookings timing volatility persists because conversion depends on customer contract end dates and facility staffing/offboarding politics, even though management says there are no internal capacity constraints. Finally, the strategic review has no communicated timeline, and no formal guidance is issued—while the 2026 expectation (+~200 bps EBITDA) is framed against ongoing operational learning curves.

AI IconGrowth Catalysts

  • Growing SaaS demand within Financial Health
  • Encoder solutions momentum: encoder pipeline growth +74% (driven by new business and channel partner ecosystem)
  • AI strategy execution in 4 pillars (financial health, patient care, customer service, internal development)
  • Pipeline dollar value at the highest in 9 quarters and +53% since beginning of Q3

Business Development

  • Microsoft partnership for Ambient Technology (pilot at a regional hospital showing improved provider time allocation/documentation reductions)
  • Exclusive Dragon Copilot integration with TruBridge EHR
  • Channel partner ecosystem contributing to Encoder pipeline growth
  • Customer reference: Artesia (New Mexico) press release tied to 50%–75% less time documenting for providers

AI IconFinancial Highlights

  • Q4 revenue: $87.2m (in line with revised guidance midpoint); -~1% YoY (includes ~-$1m from Centriq sunset); normalized YoY would be ~+1% point
  • Q4 Adjusted EBITDA: $19.2m; margin expanded +160 bps (from 20.4% in Q4’24 to 22.0% in Q4’25)
  • Full-year revenue: $346.8m (+1.4% YoY)
  • Full-year Adjusted EBITDA: $68.7m (+23% YoY) with margin expansion +350 bps
  • Gross margin: 53% in Q4 (+120 bps sequentially; flat YoY); Financial Health gross margin 50% (+65 bps vs prior period); Patient Care gross margin 59% (-75 bps vs last year)
  • Free cash flow: $20m for FY (+~$5m vs 2024)
  • Cash flow from operations: $37m for FY (+19% YoY)
  • Bookings: $19.8m TCV in Q4 (+$6m YoY, +$4m sequentially); FY bookings $82.9m TCV (+1% YoY); FY bookings $70.9m ACV

AI IconCapital Funding

  • Net debt reduced ~ $19.5m year-to-date; net leverage ~2x
  • Cash on hand: $24.9m at quarter end (up from $12.3m exited 2024)
  • Amended and restated credit agreement announced in November 2025: 5-year term expiring 2030 with up to $250m credit facilities
  • No specific buyback amount disclosed in the provided transcript (only mention of evaluating share buybacks as a capital allocation tool)

AI IconStrategy & Ops

  • Customer retention headwind tied to global workforce transition; mitigation via structured transition model (stronger oversight, better visibility across transition cycle, deeper customer collaboration)
  • Global Capacity Center (GCC) opened in Chennai (last month mentioned in call) to support cross-shore global delivery model
  • Cost optimization / margin expansion drivers: IT, cloud operations, vendor optimization, patient care support; automation leveraged to streamline workflows and improve efficiency
  • Internal finance improvements: in-house quote-to-cash centers of excellence; progress toward remediation of material weaknesses mentioned
  • Q4 and FY auditor-driven timing: out-of-period adjustments primarily noncash/non-material; related to revenue recognition, capitalized software development costs, and other nonroutine items; 10-K filed that day

AI IconMarket Outlook

  • No formal guidance due to strategic review; management expects in 2026: modest revenue growth and ~+200 bps adjusted EBITDA margin improvement
  • Strategic review: no timeline provided for when the Board will communicate outcomes

AI IconRisks & Headwinds

  • Customer retention / attrition from 2025 workforce transition in CBO customers remains a headwind; management expects only modest (flattish) improvement into 2026 (Q4 retention not quantified)
  • Bookings/revenue volatility risk: bookings timing is dependent on customer contract timing and facility onboarding/offboarding processes (no operational capacity constraints cited)
  • Patient Care softness driven by Centriq sunset: Q4 Patient Care revenue -6.6% YoY and FY Patient Care roughly flat; Centriq accounted for ~-$1m of Q4’25 revenue decline
  • Claims denial/denial-cycle friction in RCM: denials identified after 30–45 days, and corrections require time-consuming payer calls and customer documentation, described as a vicious cycle

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the TBRG Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for TBRG.

SEC EDGAR Live Feed
No recent 10-K available.
No recent 10-Q available.
Loading financial data and tables...
📁

SEC Filings (TBRG)

© 2026 Stock Market Info — TruBridge, Inc. (TBRG) Financial Profile